|Daily Range||$18.74 - $19.81|
|52-Week Range||$14.62 - $39.86|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||199,251|
|Current FY EPS||-$3.02|
Revance Therapeutics, Inc (RVNC) Description
Revance Therapeutics, Inc Website: http://www.revance.com/
Sarepta Therapeutics, Revance Therapeutics, and Cytokinetics saw big moves recently; MannKind and Orexigen could be next.
Revance Therapeutics Provides Update On RT001 Clinical Program For The Lead Indication For Crow's Feet Lines
Merger and acquisition deals and rumors were the talk of the town this week, while three additional clinical and filing updates led to double-digit percentage moves.
M&A activity sends the S&P 500 decisively higher as GW Pharmaceuticals, Revance Therapeutics, and Allergan all jump by double digits.